Elanco Animal Health Inc (NYSE:ELAN)
$ 14.07 -0.43 (-2.97%) Market Cap: 6.96 Bil Enterprise Value: 10.82 Bil PE Ratio: 35.18 PB Ratio: 1.07 GF Score: 72/100

Elanco Animal Health Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 01:40PM GMT
Release Date Price: $33.59 (-0.91%)
Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everyone, and thank you for joining us. My name is Nathan Rich, and I cover the animal health space here at Goldman. We're very pleased to introduce our next session with Elanco Animal Health. We're joined by the company's President and CEO, Jeff Simmons.

Before we jump into the Q&A, I just wanted to remind everyone on the webcast (Operator Instructions)

And with that, Jeff, thanks so much for your time, and thanks for joining us today.

Questions & Answers

Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe to start at a high level, if you could just summarize for investors, the company's in December issued guidance for 3% to 4% annual revenue growth and working towards an EBITDA margin of 31% by 2024. If achieved, that would significantly improve the company's financial profile over the next 3 years.

I guess to start, what are the key priorities, in your view, that the business needs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot